Literature DB >> 9422921

Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis.

N Okhravi1, H M Towler, P Hykin, M Matheson, S Lightman.   

Abstract

AIMS: The aim of this prospective study was, firstly, to judge the effect of early aggressive treatment with a standardised regimen of high dose broad spectrum intraocular and systemic antibiotics on visual outcome and, secondly, to assess the sensitivity of isolated organisms to the treatment regimen utilised.
METHODS: Thirty two consecutive patients presenting with presumed bacterial endophthalmitis were treated and completed follow up. In every case, intraocular sampling was undertaken and treatment with intraocular vancomycin, amikacin, and systemic ciprofloxacin was commenced immediately, followed by systemic steroids 1 day later.
RESULTS: In 69% of patients vision improved with 47% achieving a final visual acuity of 6/36 or better and 31% achieving 6/12 or better. Of the intraocular samples taken from post-surgical and post-traumatic cases, 10/27 (37%) and 3/5 (60%) were culture positive, respectively. All the bacteria isolated were sensitive to at least one of the three antibiotics used.
CONCLUSIONS: The study demonstrated that the combination of vancomycin, amikacin, and ciprofloxacin is adequate as a standard regimen for the treatment of most patients with suspected bacterial endophthalmitis. The prognosis for a good visual outcome, however, remains poor with 15/27 (55%) post-surgical and 2/5 (40%) post-traumatic cases achieving a final acuity of 6/60 or less.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422921      PMCID: PMC1722324          DOI: 10.1136/bjo.81.9.719

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  28 in total

Review 1.  Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin.

Authors:  E C Alfonso; H W Flynn
Journal:  Arch Ophthalmol       Date:  1995-11

2.  Ceftazidime or amikacin: choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis.

Authors:  B H Doft; M Barza
Journal:  Arch Ophthalmol       Date:  1994-01

3.  Intraocular lens removal from eyes with chronic low-grade endophthalmitis.

Authors:  M Busin; A Cusumano; M Spitznas
Journal:  J Cataract Refract Surg       Date:  1995-11       Impact factor: 3.351

Review 4.  Infectious endophthalmitis after cataract surgery.

Authors:  D S Hughes; R J Hill
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

5.  Posttraumatic endophthalmitis. Causative organisms, treatment, and prevention.

Authors:  D V Alfaro; D Roth; P E Liggett
Journal:  Retina       Date:  1994       Impact factor: 4.256

6.  Intracapsular and extracapsular pseudophakic endophthalmitis: a comparison.

Authors:  H E Verbraeken
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 7.  Aggressive management of an epidemic of chronic pseudophakic endophthalmitis: results and literature survey.

Authors:  N K Rogers; P D Fox; B A Noble; K Kerr; T Inglis
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

8.  Empiric treatment of endophthalmitis. Are aminoglycosides necessary?

Authors:  S P Donahue; R P Kowalski; A W Eller; J M DeVaro; B H Jewart
Journal:  Arch Ophthalmol       Date:  1994-01

9.  Treatment of endophthalmitis after cataract extraction.

Authors:  B H Doft; S F Kelsey; S Wisniewski; D J Metz; L Lobes; J Rinkoff; M Davis; A Kassoff
Journal:  Retina       Date:  1994       Impact factor: 4.256

Review 10.  Endophthalmitis in Auckland 1983-1991.

Authors:  D G Kent
Journal:  Aust N Z J Ophthalmol       Date:  1993-11
View more
  13 in total

Review 1.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Enterobacter cloacae endophthalmitis: report of four cases.

Authors:  N Okhravi; L Ficker; M M Matheson; S Lightman
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

3.  Modeling approach to characterize intraocular doripenem pharmacokinetics after intravenous administration to rabbits, with tentative extrapolation to humans.

Authors:  Oudy Semoun; Sandrine Marchand; Nicolas Grégoire; Isabelle Lamarche; Christophe Adier; Laurent Laroche; Pablo Goldschmidt; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

4.  The pharmacokinetics of linezolid in the non-inflamed human eye.

Authors:  J I Prydal; D R Jenkins; A Lovering; A Watts
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

5.  Identification of polybacterial communities in patients with postoperative, posttraumatic, and endogenous endophthalmitis through 16S rRNA gene libraries.

Authors:  Rajagopalaboopathi Jayasudha; Venkatapathy Narendran; Palanisamy Manikandan; Solai Ramatchandirane Prabagaran
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

6.  Detection of and discrimination between gram-positive and gram-negative bacteria in intraocular samples by using nested PCR.

Authors:  N M Carroll; E E Jaeger; S Choudhury; A A Dunlop; M M Matheson; P Adamson; N Okhravi; S Lightman
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 7.  Vitreous diagnosis in neoplastic diseases.

Authors:  Mónica Asencio-Duran; José Luis Vallejo-Garcia; Natalia Pastora-Salvador; Agustín Fonseca-Sandomingo; Mario R Romano
Journal:  Mediators Inflamm       Date:  2012-09-26       Impact factor: 4.711

8.  Post-clear corneal phacoemulsification endophthalmitis: profile and management outcomes at a tertiary eye care center in western India.

Authors:  Aditya S Kelkar; Jai A Kelkar; Prajakta M Barve; Aishwarya Mulay; Shubhangi Sharma; Winfried Amoaku
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-11-28

Review 9.  Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review.

Authors:  Seoh Wei Teh; Pooi Ling Mok; Munirah Abd Rashid; Mae-Lynn Catherine Bastion; Normala Ibrahim; Akon Higuchi; Kadarkarai Murugan; Rajan Mariappan; Suresh Kumar Subbiah
Journal:  Int J Mol Sci       Date:  2018-02-13       Impact factor: 5.923

10.  Acute postcataract endophthalmitis at a referral center in northern Taiwan: Causative organisms, clinical features, and visual acuity outcomes after treatment: A retrospective cohort study.

Authors:  Yi-Hao Chen; Jiann-Torng Chen; Ming-Cheng Tai; Yu-Ching Chou; Ching-Long Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.